🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Generalized anxiety disorder (GAD) is usually treated with antidepressant t...
Status
Recruiting
Location
University of Alabama - Huntsville Regional Medical Campus /ID# 267818
Start Date
2025-04-29
Trial ID
NCT06846320
Treatments Being Tested
The purpose of this study is to assess the pharmacokinetics, safety, and to...
Status
Completed
Location
Collaborative Neuroscience Research CNS /ID# 260270
Start Date
2023-08-31
Trial ID
NCT06024239
Treatments Being Tested
This study will assess the adverse events, tolerability, and how oral doses...
Status
Completed
Location
Shanghai Mental Health Center /ID# 273427
Start Date
2025-08-21
Trial ID
NCT07024797
Treatments Being Tested
The main objective of this study is to assess pharmacokinetics, safety, and...
Status
Completed
Location
Anaheim Clinical Trials LLC /ID# 254178
Start Date
2023-02-15
Trial ID
NCT05738850
The main objective of this study is to assess the safety and tolerability o...
Status
Active Not Recruiting
Location
ICON Clinical Research /ID# 270490
Start Date
2026-05-04
Trial ID
NCT06953934
Treatments Being Tested
This study will assess the adverse events and how oral ABBV-932 moves throu...
Status
Not Yet Recruiting
Location
Acpru /Id# 276951
Start Date
2026-08-21
Trial ID
NCT07071532
Treatments Being Tested
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of...
Status
Recruiting
Location
Ima Clinical Research Phoenix (Alea) /ID# 278047
Start Date
2025-09-30
Trial ID
NCT07220460
Treatments Being Tested
This study will assess the relative bioavailability and effect of food on p...
Status
Completed
Location
Acpru /Id# 266649
Start Date
2025-02-26
Trial ID
NCT06849791
The main objective of this study is to evaluate the dopamine D2 and D3 rece...
Status
Completed
Location
Parexel Early Phase Clinical Unit /ID# 264286
Start Date
2024-08-21
Trial ID
NCT06300580
Treatments Being Tested
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of...
Status
Completed
Location
Harmonex /ID# 267504
Start Date
2024-10-15
Trial ID
NCT06605599
Treatments Being Tested